158 related articles for article (PubMed ID: 23601760)
1. A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy.
Park HS; Kim HY; Park S; Kim EK; Kim SI; Park BW
Breast; 2013 Oct; 22(5):869-73. PubMed ID: 23601760
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.
Lee SK; Yang JH; Woo SY; Lee JE; Nam SJ
Br J Surg; 2013 Dec; 100(13):1756-63. PubMed ID: 24227361
[TBL] [Abstract][Full Text] [Related]
3. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
[TBL] [Abstract][Full Text] [Related]
4. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
Jakub JW; Murphy BL; Gonzalez AB; Conners AL; Henrichsen TL; Maimone S; Keeney MG; McLaughlin SA; Pockaj BA; Chen B; Musonza T; Harmsen WS; Boughey JC; Hieken TJ; Habermann EB; Shah HN; Degnim AC
Ann Surg Oncol; 2017 Oct; 24(10):2915-2924. PubMed ID: 28766196
[TBL] [Abstract][Full Text] [Related]
5. Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy-Original Study and Critical Evaluation of the Literature.
Dória MT; Maesaka JY; Soares de Azevedo Neto R; de Barros N; Baracat EC; Filassi JR
Clin Breast Cancer; 2018 Oct; 18(5):e805-e812. PubMed ID: 29798815
[TBL] [Abstract][Full Text] [Related]
6. Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy.
Shigematsu H; Kadoya T; Masumoto N; Matsuura K; Emi A; Kajitani K; Amioka A; Okada M
Clin Breast Cancer; 2014 Oct; 14(5):358-64. PubMed ID: 24962555
[TBL] [Abstract][Full Text] [Related]
7. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Schulz S; Sinn P; Golatta M; Rauch G; Junkermann H; Schuetz F; Sohn C; Heil J
Breast; 2013 Aug; 22(4):537-42. PubMed ID: 23237921
[TBL] [Abstract][Full Text] [Related]
8. An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast.
Kim S; Kim J; Park HS; Kim HY; Lee K; Lee J; Lee H; Kim JY; Kim SI; Cho YU; Park BW
Yonsei Med J; 2019 Nov; 60(11):1028-1035. PubMed ID: 31637884
[TBL] [Abstract][Full Text] [Related]
9. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
11. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
12. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
[TBL] [Abstract][Full Text] [Related]
13. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
[TBL] [Abstract][Full Text] [Related]
14. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
[TBL] [Abstract][Full Text] [Related]
15. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
Hung WK; Ying M; Chan M; Mak KL; Chan LK
Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924
[TBL] [Abstract][Full Text] [Related]
16. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
[TBL] [Abstract][Full Text] [Related]
17. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
[TBL] [Abstract][Full Text] [Related]
18. Predictors of invasive breast cancer in ductal carcinoma in situ initially diagnosed by core biopsy.
Chan MY; Lim S
Asian J Surg; 2010 Apr; 33(2):76-82. PubMed ID: 21029943
[TBL] [Abstract][Full Text] [Related]
19. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Wilkie C; White L; Dupont E; Cantor A; Cox CE
Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Brennan ME; Turner RM; Ciatto S; Marinovich ML; French JR; Macaskill P; Houssami N
Radiology; 2011 Jul; 260(1):119-28. PubMed ID: 21493791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
